Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccine

Vaccine

Volumn 29, Issue 27, 2011, Pages 4460-4468

  Adler Moore, Jill ^a   Munoz, Meilen ^a   Kim, Hana ^a   Romero, Juan ^a   Tumpey, Terrence ^b   Zeng, Hui ^b   Petro, Chris ^a   Ernst, William ^c   Kosina, Suzie ^c   Jimenez, Gretchen ^c   Fujii, Gary ^c  

^a CALIFORNIA STATE POLYTECHNIC UNIVERSITY   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c Molecular Express Inc   (United States)

Author keywords

Anti M2e antibodies; Cytokine profile; Influenza virus; Liposomal vaccine; M2e

Indexed keywords

ECTODOMAIN OF THE MATRIX 2 VACCINE; GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 4; LIPOSOME; PROTEIN M2; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; FEMALE; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; T CELL DEPLETION; TH2 CELL; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CYTOKINES; FEMALE; HUMANS; IMMUNIZATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; LIPID A; LIPOSOMES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; ORTHOMYXOVIRIDAE INFECTIONS; TH2 CELLS; VIRAL MATRIX PROTEINS;

EID: 79958143955     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.04.040     Document Type: Article

References (25)

1. Ekiert D.C., Bhabha G., Gelsliger M.A., Friesen R.H., Jongeneelen M., Throsby M., et al. Antibody recognition of a highly conserved influenza virus epitope. Science 2009, 324:246-251.
2. Sui J., Hwang W.C., Perez S., Wei G., Aird D., Chen L.M., et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 2009, 16:265-273.
3. Zebedee S.L., Lamb R.A. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol 1988, 62:2762-2772.
4. Treanor J.J., Tierney E.L., Zebedee S.L., Lamb R.A., Murphy B.R. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol 1990, 64:1375-1377.
5. Liu W., Li H., Chen Y.H. N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication. FEMS Immunol Med Microbiol 2003, 35:141-146.
6. Fan J., Liang X., Horton M.S., Perry H.C., Citron M.P., Heidecker G.J., et al. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 2004, 22:2993-3003.
7. Slepushkin V.A., Katz J.M., Black R.A., Gamble W.C., Rota P.A., Cox N.J. Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine 1995, 13:1399-1402.
8. Frace A.M., Klimov A.I., Rowe T., Black R.A., Katz J.M. Modified M2 proteins produce heterotypic immunity against influenza A virus. Vaccine 1999, 17:2237-2244.
9. Neirynck S., Deroo T., Saelens X., Vanlandschoot P., Jou W.M., Fiers W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 1999, 5:1157-1163.
10. Mozdzanowska K., Feng J., Eid M., Kragol G., Cudic M., Otvos L., et al. Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine 2003, 21:2616-2626.
11. Okuda K K., Ihata A A., Watabe S S., Okada E E., Yamakawa T T., Hamajima K., et al. Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene. Vaccine 2001, 19:3681-3691.
12. Watabe S., Xin K.-Q., Ihata A., Liu L.J., Honsho A., Aoki I., et al. Protection against influenza virus challenge by topical application of influenza DNA vaccine. Vaccine 2001, 19:4434-4444.
13. Epstein S.L., Tumpey T.M., Misplon J.A., Lo C.Y., Cooper L.A., Subbarao K., et al. DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. Emerg Infect Dis 2002, 8:796-801.
14. Jimenez G.S., Planchon R., Wei Q., Rusalov D., Geall A., Enas J., et al. Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge. Hum Vaccin 2007, 3:157-164.
15. Wang R., Song A., Levin J., Dennis D., Zhang N.J., Yoshida H., et al. Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein. Antiviral Res 2008, 80:168-177.
16. Tompkins S.M., Zhao Z.S., Lo C.Y., Misplon J.A., Liu T., Ye Z., et al. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg Infect Dis 2007, 13:426-435.
17. Jegerlehner A., Schmitz N., Storni T., Bachmann M.F. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol 2004, 172:5598-5605.
18. Fiers W., Neirynck S., Deroo T., Saelens X., Jou W.M. Soluble recombinant influenza vaccines. Philos Trans R Soc Lond B Biol Sci 2001, 356:1961-1963.
19. De Filette M., Martens W., Roose K., Deroo T., Vervalle F., Bentahir M., et al. An influenza A vaccine based on tetrameric ectodomain of matrix protein 2. J Biol Chem 2008, 283:11382-11387.
20. De Filette M., Martens W., Smet A., Schotsaert M., Birkett A., Londono-Arcila P., et al. Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies. Vaccine 2008, 26:6503-6507.
21. Fiers W., De Filette M., Birket A., Neirynck S., Min Jou W. A "universal" human influenza A vaccine. Virus Res 2004, 103:173-176.
22. Ernst W.A., Kim H.J., Tumpey T.M., Jansen A.D., Tai W., Cramer D.V., et al. Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines. Vaccine 2006, 24:5158-5168.
23. Fujii G., Ernst W., Adler-Moore J. The VesiVax system: a method for rapid vaccine development. Front Biosci 2008, 13:1968-1980.
24. Olson K., Macias P., Hutton S., Ernst W.A., Fujii G., Adler-Moore J.P. Liposomal gD ectodomain (gD1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice. Vaccine 2009, 28:548-560.
25. Gabbard J., Velappan N., Di Niro R., Schmidt J., Jones C.A., Tompkins S.M., et al. A humanized anti-M2 scFv shows protective in vitro activity against influenza. Protein Eng Des Sel 2009, 22:189-198.